Company / SG&A per Share
Alaunos Therapeutics, Inc. SG&A per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.79
FY2025
5-year range
$0.13 / $7.63
FY2021-FY2025
Trend
-63.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2013 to $7.63 in FY2024.
Based on SEC 10-K filings.
2.79 in FY2025 with a 5-year CAGR of +91.0%.
Increased from $0.82 to $2.79 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +179.5%
- 5-Year CAGR
- +91.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 63.5% year-over-year.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.79 | -63.5% |
| FY2024 | $7.63 | +830.6% |
| FY2023 | $0.82 | +542.9% |
| FY2022 | $0.13 | -1.1% |
| FY2021 | $0.13 | +17.7% |
| FY2020 | $0.11 | +19.2% |
| FY2019 | $0.09 | -8.8% |
| FY2018 | $0.10 | +3242.1% |
| FY2013 | $0.00 | -16.9% |
| FY2012 | $0.00 | -97.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026